Long
Bullish on AEZS . Stock crosses key indicators!
We have been monitoring AAEZS for sometime. The stock has crossed key technical indicators. We are bullish.
We are are confident the stock will remain relatively stable now that the base of support is forming above the 200EMA. We will also look to buy the stock on weakness. Given that this is a BIOTECH that is dependant on clinical trials and FDA approval, huge swings could occur based on those outcomes.
Should the stock fall below the 200EMA and develops negative indicators, we will re-evaluate our position.
Our target price for this stock is $5.00 (fair value)
We are are confident the stock will remain relatively stable now that the base of support is forming above the 200EMA. We will also look to buy the stock on weakness. Given that this is a BIOTECH that is dependant on clinical trials and FDA approval, huge swings could occur based on those outcomes.
Should the stock fall below the 200EMA and develops negative indicators, we will re-evaluate our position.
Our target price for this stock is $5.00 (fair value)
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.